Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition

David Goyard, Bálint Kónya, Aikaterini S. Chajistamatiou, Evangelia D. Chrysina, Jérémy Leroy, Sophie Balzarin, Michel Tournier, Didier Tousch, Pierre Petit, Cédric Duret, Patrick Maurel, L. Somsák, T. Docsa, P. Gergely, Jean Pierre Praly, Jacqueline Azay-Milhau, Sébastien Vidal

Research output: Contribution to journalArticle

35 Citations (Scopus)

Fingerprint Dive into the research topics of 'Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences